← Open Payments lookup

GEORGE BLAIR II: Open Payments

NPI 1588678973 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,401 in 56 payments from 9 companies in 2025. Trend: 2023 $933 · 2024 $1,845 · 2025 $1,401

Food & beverage: $1,292Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$445
Janssen Pharmaceuticals, Inc10$256
E.R. Squibb & Sons, L.L.C.11$236
Otsuka America Pharmaceutical, Inc.7$143
Vanda Pharmaceuticals Inc.5$107
Alkermes, Inc.4$99
Luye Pharma (USA) Ltd.4$69
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Lundbeck LLC1$20

Products named: AUSTEDO XR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, FANAPT, ARISTADA, COBENFY, UZEDY, ERZOFRI EXTENDED-RELEASE.

Industry payments across CA — which companies pay providers there.